Susquehanna International Group
LOXO

Susquehanna International Group’s Loxo Oncology, Inc LOXO Stock Holding History

Susquehanna International Group’s Portfolio LOXO Stock Details LOXO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-117,400
Closed -$16.4M – 10496
2018
Q4 		$16.4M Sell
117,400
-4,600
-4% -$698K 0.01% 1203
2018
Q3 		$20.8M Sell
122,000
-1,300
-1% -$218K 0.01% 1300
2018
Q2 		$21.4M Buy
123,300
+55,100
+81% +$8.28M 0.01% 1240
2018
Q1 		$7.87M Sell
68,200
-65,700
-49% -$6.99M ﹤0.01% 2030
2017
Q4 		$11.3M Buy
133,900
+86,000
+180% +$7.17M ﹤0.01% 1726
2017
Q3 		$4.41M Buy
47,900
+37,900
+379% +$2.94M ﹤0.01% 2661
2017
Q2 		$802K Buy
+10,000
New +$554K ﹤0.01% 5723

Other funds holding LOXO

IUHSA
Itau Unibanco Holding S.A. Sao Paulo, Brazil $4.31B AUM 46.57% 1-Year Est. Return

Susquehanna International Group's LOXO Position: Q1 2019 in Review

Susquehanna International Group sold out of Loxo Oncology, Inc (LOXO) in Q1 2019, closing a stake of 4,201 shares — an estimated $588K sold.

Susquehanna International Group first reported a position in LOXO in Q3 2014 and held it in 4 quarters. The position peaked at $4.03M in Q2 2018. 1 fund tracked by Wall St. Rank holds LOXO as of Q1 2019.

  • Susquehanna International Group reported no remaining Loxo Oncology, Inc position as of Q1 2019 after selling out during the quarter.
  • Susquehanna International Group sold 4,201 Loxo Oncology, Inc shares in Q1 2019, an estimated $588K.
  • Susquehanna International Group first reported a position in Loxo Oncology, Inc in Q3 2014 and held it in 4 quarters.
  • Susquehanna International Group's Loxo Oncology, Inc position peaked at $4.03M in Q2 2018.
  • 1 fund tracked by Wall St. Rank held Loxo Oncology, Inc as of Q1 2019.

Based on Susquehanna International Group's 13F filing for Q1 2019, filed 15 May 2019.